Abstract
THE anti-arrhythmic action of guanethidine which was found to prevent a type of clinical paroxysmal ventricular tachycardia1 and prevented experimental atrial fibrillation2 suggested that other agents which interfere with the release of catecholamines might exhibit similar effectiveness.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
